» Articles » PMID: 37121109

The Role of Child Neurologists in the Management of Motor Disability in Cerebral Palsy: Establishing the Path Forward

Overview
Journal Pediatr Neurol
Specialties Neurology
Pediatrics
Date 2023 Apr 30
PMID 37121109
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cerebral palsy (CP) is the most common motor disability of childhood, and yet the role of child neurologists and neurodevelopmentalists (CN/NDDs) in the management of children with CP is unclear. Although previous surveys showed that CN/NDDs believe they are uniquely expert in CP motor phenotyping and should be involved in CP management, others have demonstrated that training in CP management among CN/NDD residency programs is inadequate.

Methods: In this article, we surveyed a group of CN/NDDs at the Child Neurology Society Cerebral Palsy Special Interest Group meeting on January 27, 2022. Questions addressed provider comfort with CP tone management including motor phenotyping, pharmacologic and surgical management, barriers and solutions to improving practice, and the use of systems-based care.

Results: Responses from 42 participants demonstrated that CN/NDDs lack experience with CP tone management, with 48% and 58% of respondents reporting little to no experience in pharmacologic or surgical management, respectively. Primary barriers identified to improving comfort with CP tone management included lack of knowledge and ineffective treatment options, while most solutions centered on improving collaborations between CN/NDDs and other specialties. Only 50% of respondents reported currently using systems-based care in the management of patients with CP.

Conclusions: An interdisciplinary, systems-based care model would allow for collaboration and knowledge sharing between involved specialties and provide high-value goal-directed care to maximize the functional outcomes for every individual with CP.

References
1.
Aravamuthan B, Shevell M, Kim Y, Wilson J, OMalley J, Pearson T . Role of child neurologists and neurodevelopmentalists in the diagnosis of cerebral palsy: A survey study. Neurology. 2020; 95(21):962-972. PMC: 7734737. DOI: 10.1212/WNL.0000000000011036. View

2.
Masson R, Pagliano E, Baranello G . Efficacy of oral pharmacological treatments in dyskinetic cerebral palsy: a systematic review. Dev Med Child Neurol. 2017; 59(12):1237-1248. DOI: 10.1111/dmcn.13532. View

3.
Novak I, Hines M, Goldsmith S, Barclay R . Clinical prognostic messages from a systematic review on cerebral palsy. Pediatrics. 2012; 130(5):e1285-312. DOI: 10.1542/peds.2012-0924. View

4.
Ashwal S, Russman B, Blasco P, Miller G, Sandler A, Shevell M . Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2004; 62(6):851-63. DOI: 10.1212/01.wnl.0000117981.35364.1b. View

5.
Rosenbaum P, Gorter J . The 'F-words' in childhood disability: I swear this is how we should think!. Child Care Health Dev. 2011; 38(4):457-63. DOI: 10.1111/j.1365-2214.2011.01338.x. View